top of page
< Back

胰島β細胞功能測試 | BChealth


Precise treatment with precise diagnosis

Price | 價錢


胰島β細胞功能測試 — 精準診斷配合精準治療

BChealth — Precise treatment with precise diagnosis


Classify Your Diabetes Type Precisely



Different types of diabetes have similar clinical characteristics. At present, doctors mostly use the stepwise elimination method to distinguish the patient's diabetes type and determine a treatment plan. Unfortunately, this method is time-consuming and has low efficiency. Failure to correctly classify the type of diabetes causes many patients to miss the optimal timeframe for treatment.

Doctors can use our test to accurately identify the patient's type of diabetes and decide on treatment options.


Do you know?


The Importance Of Testing Diabetes





According to a jointly published report by two reputable diabetes organizations, the American Diabetes Association and the European Association for Study of Diabetes, it is recommended to test patients for C peptide and islet cell antibodies for diabetes classification.¹ An International Experts Group also recommended C-peptide and islet cell antibody tests as a method for diagnosis and management of latent autoimmune diabetes in adults (LADA)².

For non-diabetes individuals, high insulin resistance and low B-cell function increase the risk of developing diabetes up to 5-fold. For diabetes patient, the time to insulin requirement is at least 8 years earlier on average.³

1.Holt, Richard I. G., et al. “The Management of Type 1 Diabetes in Adults. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).” Diabetologia, vol. 64, no. 12, 2021, pp. 2609–2652.,
2.Buzzetti, Raffaella, et al. “Management of Latent Autoimmune Diabetes in Adults: A Consensus Statement From an International Expert Panel.” Diabetes, vol. 69, no. 10, 2020, pp. 2037–2047.,
3.Fan B, Wu H, Shi M, Yang A, Lau ESH, Tam CHT, Mao D, Lim CKP, Kong APS, Ma RCW, Chow E, Luk AOY, Chan JCN. Associations of the HOMA2-%B and HOMA2-IR with progression to diabetes and glycaemic deterioration in young and middle-aged Chinese. Diabetes Metab Res Rev. 2022 Jul;38(5):e3525. doi: 10.1002/dmrr.3525. Epub 2022 Mar 8. PMID: 35174618; PMCID: PMC9542522.





pdf logo.png

← 點擊查看胰島β細胞功能測試小冊子 | View BChealth Leaflet

bottom of page